Citadel Advisors LLC 13D and 13G filings for Dyne Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 4:23 pm Sale |
2024-09-30 | 13G | Dyne Therapeutics, Inc. DYN |
Citadel Advisors LLC | 2,960,081 3.000% |
-112,506 (-3.66%) |
Filing |
| 2024-02-14 4:57 pm Purchase |
2023-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
Citadel Advisors LLC | 3,072,587 5.000% |
91,263 (+3.06%) |
Filing |
| 2023-02-14 08:02 am Purchase |
2022-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
Citadel Advisors LLC | 2,981,324 5.700% |
116,524 (+4.07%) |
Filing |
| 2022-02-14 06:12 am Sale |
2021-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
Citadel Advisors LLC | 2,864,800 5.600% |
-299,601 (-9.47%) |
Filing |
| 2021-02-16 4:30 pm Purchase |
2020-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
Citadel Advisors LLC | 3,164,401 7.000% |
218,450 (+7.42%) |
Filing |
| 2020-09-28 4:03 pm Purchase |
2020-09-17 | 13G | Dyne Therapeutics, Inc. DYN |
Citadel Advisors LLC | 2,945,951 6.500% |
2,945,951 (New Position) |
Filing |